STONY BROOK, N.Y. – July 13, 2023 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced that it has acquired Spindle Biotech Inc. (“Spindle”), an early-stage, private biotech company developing next-generation RNA manufacturing technologies. The acquisition uniquely leverages the Company’s LinearDNA™ [...]
A novel approach of using a DNA therapeutic platform with a Lipid Nanoparticle (LNP)-based delivery system and focused on veterinary vaccine applications has been evaluated and our preliminary results are reported in this white paper. The studies shown herein support the advancement of high-fidelity, PCR-produced linearDNA™ in vaccine applications, taking advantage of [...]
STONY BROOK, N.Y. - June 8, 2023 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”), a leader in PCR-based DNA technologies, today announced that it has been invited to present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest, on June 20-22, 2023. Dr. James A. [...]
By Applied DNA Sciences | June 1, 2023 A new article titled “They Are Not Fakes, They Are Dupes: They Appeal to Those Who Say They Are Green” sheds light on a growing concern in the world of brand protection and authenticity. The growing popularity of “dupes” or [...]
By Applied DNA Sciences | May 15, 2023 Applied DNA has been featured on the front page of the New York Times, in a recent article titled “AI Technology Meets DNA to Transform Supply Chains.” The article explores how Applied DNA’s groundbreaking advancements are revolutionizing supply chain management by combining [...]
STONY BROOK, N.Y. - May 11, 2023 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced consolidated financial results for the second quarter of fiscal 2023 ended March 31, 2023. Commenting on the Company’s quarterly performance, Dr. James A. Hayward, president and [...]
STONY BROOK, N.Y. – May 3, 2023 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release financial results for the three months ended March 31, 2023 after the market close on Thursday, May 11, 2023. The Company [...]
STONY BROOK, N.Y. – April 7, 2023 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (the "Company"), a leader in PCR-based DNA technologies, announced that its CertainT® supply chain traceability platform is featured in an article on the home page of the New York Times website today. The article, titled "How A.I. and DNA Are [...]
STONY BROOK, N.Y. – March 29, 2023 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that it has established a new high bar for the production of DNA with the manufacture and shipment of a multi-gram quantity of linearDNA™ in under six weeks. The quantity [...]